BRIDGEWAY CAPITAL MANAGEMENT, LLC - SINGULAR GENOMICS SYSTEMS IN ownership

SINGULAR GENOMICS SYSTEMS IN's ticker is OMIC and the CUSIP is 82933R100. A total of 77 filers reported holding SINGULAR GENOMICS SYSTEMS IN in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.1%.

Quarter-by-quarter ownership
BRIDGEWAY CAPITAL MANAGEMENT, LLC ownership history of SINGULAR GENOMICS SYSTEMS IN
ValueSharesWeighting
Q3 2023$105,728
-54.1%
277,5000.0%0.00%
-50.0%
Q2 2023$230,325
-15.2%
277,500
+23.7%
0.01%
-14.3%
Q1 2023$271,524
-40.6%
224,400
-1.4%
0.01%
-41.7%
Q4 2022$457,275
+1424.2%
227,500
+1811.8%
0.01%
+1100.0%
Q3 2022$30,000
-42.3%
11,900
-11.9%
0.00%0.0%
Q2 2022$52,00013,5000.00%
Other shareholders
SINGULAR GENOMICS SYSTEMS IN shareholders Q2 2022
NameSharesValueWeighting ↓
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 9,112,019$250,398,0004.45%
Casdin Capital, LLC 2,692,870$74,000,0001.88%
Perceptive Advisors 6,165,740$169,434,0001.10%
Nicholas Investment Partners, LP 629,716$17,305,0001.08%
Mitsubishi UFJ Morgan Stanley Securities Co., Ltd. 3,440$95,0000.71%
Orbimed Advisors 1,998,521$54,919,0000.56%
Alphabet Inc. 646,622$17,769,0000.36%
Pinz Capital Management, LP 36,400$1,000,0000.30%
NEXPOINT ASSET MANAGEMENT, L.P. 39,142$1,076,0000.24%
Coatue Management 2,119,614$58,247,0000.23%
View complete list of SINGULAR GENOMICS SYSTEMS IN shareholders